177 related articles for article (PubMed ID: 35915454)
1. Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections.
Tzivian L; Sokolovska J; Grike AE; Kalcenaua A; Seidmann A; Benis A; Mednis M; Danovska I; Berzins U; Bogdanovs A; Syundyukov E
Health Qual Life Outcomes; 2022 Aug; 20(1):120. PubMed ID: 35915454
[TBL] [Abstract][Full Text] [Related]
2. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy.
Matejko B; Skupien J; Mrozińska S; Grzanka M; Cyganek K; Kiec-Wilk B; Malecki MT; Klupa T
Endocrine; 2015 Feb; 48(1):164-9. PubMed ID: 24798448
[TBL] [Abstract][Full Text] [Related]
5. Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study.
Mesbah NI; Taha NA; Rahme ZN; Sukkar FF; Omar DM
Med Princ Pract; 2020; 29(3):255-261. PubMed ID: 31557759
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
7. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
[TBL] [Abstract][Full Text] [Related]
8. A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion.
Kamoi K; Miyakoshi M; Maruyama R
Diabetes Res Clin Pract; 2004 Apr; 64(1):19-25. PubMed ID: 15036823
[TBL] [Abstract][Full Text] [Related]
9. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
[TBL] [Abstract][Full Text] [Related]
10. 'The pump was a saviour for me.' Patients' experiences of insulin pump therapy.
Garmo A; Hörnsten Å; Leksell J
Diabet Med; 2013 Jun; 30(6):717-23. PubMed ID: 23398606
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal versus subcutaneous insulin therapy in the treatment of type 1 diabetes mellitus.
van Dijk PR; Logtenberg SJ; Hendriks SH; Groenier KH; Feenstra J; Pouwer F; Gans RO; Kleefstra N; Bilo HJ
Neth J Med; 2015 Nov; 73(9):399-409. PubMed ID: 26582805
[TBL] [Abstract][Full Text] [Related]
12. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
[TBL] [Abstract][Full Text] [Related]
13. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
[No Abstract] [Full Text] [Related]
14. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
15. Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents.
Alsaleh FM; Smith FJ; Thompson R; Al-Saleh MA; Taylor KM
Int J Clin Pharm; 2014 Oct; 36(5):1023-30. PubMed ID: 25108411
[TBL] [Abstract][Full Text] [Related]
16. Impact of the Omnipod
Polonsky WH; Hessler D; Layne JE; Zisser H
Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
[TBL] [Abstract][Full Text] [Related]
18. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
[TBL] [Abstract][Full Text] [Related]
20. Impact of diabetes education on type 1 diabetes mellitus control in children.
Alonso Martín DE; Roldán Martín MB; Álvarez Gómez MÁ; Yelmo Valverde R; Martín-Frías M; Alonso Blanco M; Barrio Castellanos R
Endocrinol Nutr; 2016 Dec; 63(10):536-542. PubMed ID: 27765490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
